Relx Plc (NYSE:RELX) Shares Sold by Eagle Ridge Investment Management

Eagle Ridge Investment Management cut its holdings in shares of Relx Plc (NYSE:RELX) by 1.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 312,737 shares of the technology company’s stock after selling 3,864 shares during the quarter. Eagle Ridge Investment Management’s holdings in Relx were worth $14,205,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in RELX. Marshall Wace LLP acquired a new stake in Relx during the 2nd quarter worth approximately $312,000. AQR Capital Management LLC acquired a new stake in Relx during the 2nd quarter worth approximately $433,000. Cetera Investment Advisers lifted its holdings in Relx by 0.6% during the 2nd quarter. Cetera Investment Advisers now owns 61,005 shares of the technology company’s stock worth $2,799,000 after buying an additional 339 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Relx by 21.4% during the 3rd quarter. GAMMA Investing LLC now owns 9,804 shares of the technology company’s stock worth $465,000 after buying an additional 1,727 shares in the last quarter. Finally, Dynamic Advisor Solutions LLC acquired a new stake in Relx during the 3rd quarter worth approximately $248,000. 15.02% of the stock is currently owned by institutional investors and hedge funds.

Relx Stock Down 0.8 %

Shares of NYSE:RELX opened at $50.37 on Friday. The company’s fifty day moving average price is $47.33 and its 200 day moving average price is $46.92. Relx Plc has a 12 month low of $40.25 and a 12 month high of $50.84. The company has a current ratio of 0.48, a quick ratio of 0.42 and a debt-to-equity ratio of 1.63.

Analyst Ratings Changes

RELX has been the topic of a number of analyst reports. StockNews.com initiated coverage on shares of Relx in a report on Wednesday, October 30th. They issued a “hold” rating on the stock. Redburn Atlantic initiated coverage on shares of Relx in a research note on Wednesday, January 8th. They set a “buy” rating on the stock.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.